期刊
NEUROGASTROENTEROLOGY AND MOTILITY
卷 26, 期 2, 页码 264-271出版社
WILEY
DOI: 10.1111/nmo.12259
关键词
defecation; ghrelin; ghrelin receptors
资金
- Transport Accident Commission of Victoria
- National Health and Medical Research Council of Australia [1005811]
BackgroundDiscovery of adequate pharmacological treatments for constipation has proven elusive. Increased numbers of bowel movements were reported as a side-effect of ulimorelin treatment of gastroparesis, but there has been no investigation of the site of action. MethodsAnesthetized rats were used to investigate sites and mechanisms of action of ulimorelin. Key ResultsIntravenous ulimorelin (1-5mg/kg) caused a substantial and prolonged (similar to 1h) increase in colorectal propulsive activity and expulsion of colonic contents. This was prevented by cutting the nerves emerging from the lumbosacral cord, by the nicotinic receptor antagonist hexamethonium and by antagonists of the ghrelin receptor. The effect of intravenous ulimorelin was mimicked by direct application of ulimorelin (5g) to the lumbosacral spinal cord. Conclusions & InferencesUlimorelin is a potent prokinetic that causes propulsive contractions of the colorectum by activating ghrelin receptors of the lumbosacral defecation centers. Its effects are long-lasting, in contrast with other colokinetics that target ghrelin receptors.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据